More Than 100 Exhibitors Take Part In Inaugural BioITWorld Conference & Expo

FRAMINGHAM, MA – MARCH 19, 2002 – IDG World Expo, the leading producer of world-class tradeshows, conferences and events for IT markets, today announced that exhibitor and attendee participation at the inaugural BioITWorld Conference & Expo exceeded expectations, attracting more than 100 exhibitors and 3,976 total participants. BioITWorld Conference & Expo, held last week at the World Trade Center Boston, was created to address the emerging Bio-IT industry the merging of information technologies and life sciences, and the resulting transformation of the entire discovery and development process.

 

"The success of BioITWorld Conference & Expo clearly demonstrates a massive demand for information technology solutions tailored to life sciences," said Charlie Greco, president and CEO of IDG World Expo. "After last week's event, we believe more than ever that IT and life sciences professionals need to continue to communicate, learn from each other and find common ground. BioITWorld was an ideal environment for this, providing networking opportunities, peer-to-peer learning and a showcase of the newest products."

"BioITWorld has been a terrific forum for EMC to connect with researchers, scientists, IT managers, and partners," said Roberta Katz, EMC's Life Sciences Group Marketing Manager. "We were pleased with the opportunity to showcase EMC solutions, which help accelerate the drug discovery process, and the overall event attendance. We look forward to expanding our presence this summer at BioITWorld San Francisco."

Exhibitors Roll Out New IT Solutions

Sun Microsystems and Accelrys were on hand to discuss the expansion of their long-standing alliance in the life sciences market. The companies plan to jointly support the development of Discovery Studio, Accelrys' forthcoming platform for accelerating pre-clinical drug research.

Inforonics Life Sciences and Hewlett-Packard Company announced Accelerated Development Solutions (ADS) to better assess, manage and improve the drug development process from discovery to launch.

AVAKI Corporation announced three customer wins. Gene Logic Inc., Infinity Pharmaceuticals and Structural Bioinformatics, Inc. (SBI), will use AVAKI's technology to provide shared access to critical data and applications and improve the utilization of information technology resources. As a result, these companies can speed their data and analytic products to market helping to accelerate the drug discovery process.

Acero, a new company with roots in enterprise software and life sciences, announced market availability of the industry's first "science-intelligent"(TM) enterprise software platform. The Genomics Knowledge Platform intelligently integrates data, applications and researchers, eliminating the computational barriers that currently exist in life-sciences knowledge discovery.

Visionaries Share Learnings, Spark Discussions

Dr. Eric Lander, founder and director of the MIT Whitehead Institute Center for Genome Research, presented the opening keynote presentation to a standing-room only crowd. Lander offered insight on the Human Genome Project and the contributions IT continues to make to its progress. Dr. Lander emphasized that while "we indeed have the keys to this remarkable library" of genomic information, "we still don't know how to use it fully." Lander pointed out that the market opportunity far outstrips the number of people available in the field, with the industry currently being understaffed by a factor of 50.

Roy Dunbar, CIO of Eli Lilly and Company, discussed the value of IT in pharmaceutical research, focusing his presentation on how Eli Lilly is leveraging meaningful outcomes from the technologies driving the biological and information sciences revolution. Michael Capellas, chairman and CEO of Compaq Computer Corporation, discussed key growth factors for Bio-IT, including the exponential growth of computing performance; greater collaboration among government, academic institutions and the industry; and proven market success in developing new products.

The IDC Symposium, hosted by Debra Goldfarb, IDC group vice president of Worldwide Systems and Life Sciences Research, offered a market snapshot of Bio-IT. Goldfarb shared results of new research from IDC which predicts that the Bio-IT market will grow from $10.4 billion in 2000 to nearly $38 billion in 2006, representing a 24% compound annual growth rate.

The IBM Symposium, moderated by Dr. Sharon Nunes, director of solutions development for IBM Life Sciences, featured panelists John Murphy, CIO of CuraGen; Manuel J. Glynias, president and CEO of NetGenics and Adel Mikhail, senior vice president of LabBook. Each company offered insights on key success factors, pitfalls and outlooks for building IT infrastructure for a life sciences organization.

The event also featured ten workshops and 35 conference sessions taught by industry visionaries, covering topics ranging from drug discovery to bioinformatics platforms to seed capital financing. Popular sessions included "Leveraging and Positioning Bioinformatics & Genomics for Drug Discovery," "The Use of IT to Speed Drug Discovery," "Successful Business Models in the Growing Bioinformatics Industry," and "The Bioinformatics Inside Proteomics."

BioITWorld Venture Summit

The BioITWorld Venture Summit offered an opportunity for privately-held Bio-IT companies to connect with interested venture capitalists, incorporating both business meeting presentations and an exclusive reception. The trade show setting of the BioITWorld Venture Summit differentiated the event from similar investor meetings. During the day-long summit,13 young bioinformatics and biotechnology companies presented their business plans and technologies to a group of influential venture capitalists and investors.

"One of the most challenging aspects to creating a new company is the ability to raise capital," said meeting organizer and Director of Bioinformatics for CuraGen Corporation Jim Golden. "BioITWorld offered a unique opportunity to bring entrepreneurs and investors in the biotechnology and IT space together in the context of a technology-centered meeting. VCs from different firms could hear the company founder present the company overview and then walk down to the exhibit floor and see that company in action with potential customers. I think it was a great opportunity for both groups of people. We've had very good feedback from the investor and business communities ? we'll definitely do it again in San Francisco."

The next BioITWorld Conference & Expo will take place in San Francisco from August 13-15, 2002 at the Moscone Center. BioITWorld will return to Boston again March 25 – 27, 2003, at the Hynes Convention Center. For more information, visit www.bioitworld.com.

About BioITWorld

BioITWorld Conference & Expo (www.bioitworld.com), produced by IDG World Expo, is the first event to demonstrate how information technology is transforming life sciences throughout the entire discovery and development processes. IDG World Expo designed BioITWorld for life sciences professionals looking to evaluate and understand the advanced IT solutions and bioinformatics that help revolutionize our health, our environment and our society. Visionaries from the biotechnology, pharmaceutical, academic and government markets will convene at BioITWorld to learn how the latest tools, services and training can speed, store, analyze and interpret the flood of information being produced by the life sciences industry.

For More Information

For more information on BioITWorld Conference & Expo please contact Ryan Colby, Product Manager at (508) 424-4811 or via email at ryan_colby@idg.com. More information is also available by calling (800) 560-7612.

About IDG World Expo

IDG World Expo (www.idgworldexpo.com) produces IT-focused tradeshows, conferences and events for professionals seeking world-class education, peer-to-peer networking and one-stop comparison shopping. As the leading IT event management company, IDG World Expo leverages its experience and knowledge of IT-focused events and conferences, enabling technology companies to capture the attention and loyalty of influential buyers. IDG World Expo's portfolio of conferences and events includes Macworld Conference & Expo, LinuxWorld Conference & Expo, BioITWorld Conference & Expo and COMNET Conference & Expo. IDG World Expo is a business unit of IDG, the world's leading technology media, research and event company.

About IDG

IDG publishes more than 300 magazines and newspapers and offers online users the largest network of technology-specific sites around the world through IDG.net (www.idg.net), which comprises more than 300 targeted Web sites in 70 countries. IDG is also a leading producer of 168 computer-related events worldwide, and provides IT market analysis through 51 offices in 43 countries worldwide. Company information is available at www.idg.com.

 

###